| Drug Name: | Clobutinol (14860-49-2) |
|---|---|
| PubChem ID: | 26937 |
| SMILES: | CC(CN(C)C)C(C)(CC1=CC=C(C=C1)Cl)O |
| InchiKey: | KVHHQGIIZCJATJ-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 255.789 |
| LogP | : | 2.8312 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 23.47 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Dry Mouth | Kappa-Type opioid receptor (P41145) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
| Insomnia | Kappa-Type opioid receptor (P41145) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|